Identification of the monocarboxylate transporter 1 as a target of a new class of immunosuppressants shows that aerobic glycolysis and lactate release are essential for the proliferation of activated lymphocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bröer, S. et al. Biochem. J. 333, 167–174 (1998).
Halestrap, A.P. & Price, N.T. Biochem. J. 343, 281–299 (1999).
Murray, C.L. et al. Nat. Chem. Biol. 1, 372–377 (2005).
Michne, W.F. et al. J. Med. Chem. 38, 2557–2569 (1995).
Magistretti, P.J., Pellerin, L., Rothman, D.L. & Shulman, R.G. Science 283, 496–497 (1999).
Gladden, L.B. J. Physiol. (Lond.) 558, 5–30 (2004).
Chih, C.P., Lipton, P. & Roberts, E.L., Jr . Trends Neurosci. 24, 573–578 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bröer, S. Lactate transportation is required for lymphocyte activation. Nat Chem Biol 1, 356–357 (2005). https://doi.org/10.1038/nchembio1205-356
Issue Date:
DOI: https://doi.org/10.1038/nchembio1205-356
This article is cited by
-
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
Nature Reviews Urology (2020)
-
The SLC38 family of sodium–amino acid co-transporters
Pflügers Archiv - European Journal of Physiology (2014)
